The global market for RNAi technology is estimated to be USD 8.7 billion
in 2014 and is expected to reach USD21.9 billion by 2019, growing at a CAGR of
20.19%
RNA interference (RNAi) is a natural process of treating forms of cancer
and other diseases by post-transcriptional silencing of genes by small
fragments of the nucleic acid. However, the path of RNAi therapies to the
clinic has been more like a roller-coaster ride. RNAi technology can be helpful
in providing target specificity to the proteins that lack the enzymatic pocket necessary
for binding.
Global RNAi Technology Market-Market Dynamics
Global RNAi Technology Market-Market Dynamics
Request a sample
of this report @ http://www.orbisresearch.com/contacts/request-sample/219740 .
The major drivers for the growth of the market are improving synthetic
delivery carriers and chemical modifications to RNA, increasing genetic and
metabolic disorders including diseases like cancer and increasing applications
in molecular diagnostics, particularly that of cancer. However, the market is
facing major challenges because of strict FDA regulations and the fact that RNA
is potentially immunogenic and inherently unstable, which causes major problems
for the research and development of drugs. Greatly expanding the number of
druggable disease targets and potentially streamlining drug development are the
market growth opportunities in the coming years.
RNAi technology is showing promise in the treatment of viral infections
like hepatitis B virus (HBV), which affects more than 300 million worldwide,
killing at least 780,000 annually through liver scarring, liver failure, and
liver cancer. There has been a shift in strategic focus of RNAi innovators from
RNAi triggers to delivery. Small RNAi therapeutics innovator (pure-play)
companies and Big Pharma remain the industry's two protagonists, although
medium-sized pharmaceutical companies, including those in Asian countries, have
taken some of the space vacated by Big Pharma. RNAi technology has application in
different sectors like drug discovery and development and therapeutics.
Therapeutics is the major growing sector owing to the increased demand for
treatment of cancer and liver disorders.
The market is segmented by type of application (drug discovery and
development, therapeutics, and others), by therapeutics (oncology, ocular
disorders, respiratory disorders, liver diseases, and neuronal disorders) and
geography (North America, Europe, and Asia-Pacific).
The key players in the market are focused on the expansion of their
business by launching new products and extending the product line. Mergers and
acquisitions of small and medium-sized manufacturers to enter the overseas
market is another strategy adopted by multinational players. RNAi technologies
market is still at their nascent stage but companies are keen on taking this
market to a higher level.
Purchase a copy of
Global RNAi Technology
Market visit @ http://www.orbisresearch.com/contact/purchase/219740 For
more information contact sales@orbisresearch.com .
Some of the key
players in the market are:
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
Alnylam Pharmaceuticals
Benitec Biopharma Ltd
Filmtec Corporation
Ionis Pharmaceuticals
Quark Pharmaceuticals Inc.
RXI Pharmaceuticals
What the Report
Offers
Market definition of RNAi technology market along with identification of key drivers and restraints for the market.
Market analysis for the RNAi technology, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
An exhaustive understanding of the worldwide market for RNAi technology.
A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
Wide-ranging information provided about the leading market players and the major strategies adopted by them.
Market definition of RNAi technology market along with identification of key drivers and restraints for the market.
Market analysis for the RNAi technology, with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
An exhaustive understanding of the worldwide market for RNAi technology.
A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade.
An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.
Wide-ranging information provided about the leading market players and the major strategies adopted by them.
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-rnai-technology-market-growth-trends-and-forecasts-2017-2022 .
Some
Points From TOC :
1. INTRODUCTION
1.1 Market Definition
1.2 Market Size Estimation
1.1 Market Definition
1.2 Market Size Estimation
2. RESEARCH METHODOLOGY
2.1 Market Share Estimation
2.2 Key Data from Secondary Sources
2.3 Key Data from Primary Sources
2.1 Market Share Estimation
2.2 Key Data from Secondary Sources
2.3 Key Data from Primary Sources
3. EXECUTIVE SUMMARY
4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Improving synthetic delivery carriers and chemical modifications to RNA
4.2.1.2 Increasing genetic and metabolic disorders
4.2.1.3 Increasing applications in molecular diagnostics, particularly that of cancer
4.2.2 Restraints
4.2.2.1 Strict FDA regulations
4.2.2.2 RNA is inherently unstable, potentially immunogenic.
4.2.3 Opportunities
4.2.3.1 Greatly expanding the number of druggable disease targets and potentially streamlining drug development
4.3 Market Share Analysis, By Key Players
4. MARKET OVERVIEW
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Improving synthetic delivery carriers and chemical modifications to RNA
4.2.1.2 Increasing genetic and metabolic disorders
4.2.1.3 Increasing applications in molecular diagnostics, particularly that of cancer
4.2.2 Restraints
4.2.2.1 Strict FDA regulations
4.2.2.2 RNA is inherently unstable, potentially immunogenic.
4.2.3 Opportunities
4.2.3.1 Greatly expanding the number of druggable disease targets and potentially streamlining drug development
4.3 Market Share Analysis, By Key Players
5. INDUSTRY TRENDS
5.1 Value Chain Analysis
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining power of Buyers
5.2.2 Bargaining power of Suppliers
5.2.3 Degree of Competition
5.2.4 Threat of new entrants
5.2.5 Threat of Substitutes
5.1 Value Chain Analysis
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining power of Buyers
5.2.2 Bargaining power of Suppliers
5.2.3 Degree of Competition
5.2.4 Threat of new entrants
5.2.5 Threat of Substitutes
About Us:
Orbis Research (orbisresearch.com) is a
single point aid for all your market research requirements. We have vast
database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our
clients. We have complete information about our publishers and hence are sure
about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required
market research study for our clients.
Contact
Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1
(214) 884-6817; +9164101019
No comments:
Post a Comment